Purchase this article with an account.
Gustavo Vela, Stephanie Voorduin; Retrospective study of clinical results in patients diagnosed with pars planitis treated with via pars plana vitrectomy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2544.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To retrospectively analyze the clinical results of patients diagnosed with pars planitis at the Nuestra Señora de la Luz Hospital, specifically of those which underwent via pars plana vitrectomy.
We made a retrospective and observational study of clinical histories of 20 patients which underwent vitrectomy at the Nuestra Señora de la Luz Hospital between the years 2007 and 2012.
From the 20 patients 15 were male and 5 female. Their ages went from 4 to 17. None of the patients had undergone surgery before. All of them had received paraocular or systemic corticosteroids, and 19/23 (eyes) were treated with immunomodulators. The most common surgery indication was cataract. Sixty percent of the surgeries were performed within twelve months of the diagnosis. The average time the patients were followed was 29 months. Sixty five percent of the patients had an improved visual acuity after the procedure. Sixty percent of the patients required no additional treatment after the procedure. Only five eyes had intraoperative complications, fourty four percent had postsurgical complications.
Vitrectomy is a safe and efficient therapeutic option for the treatment of pars planitis. It has been traditionally used for complicated cases that do not respond to medical treatment (glucocorticoids and immunomodulators). The results in this study support the fact that vitrectomy should be considered an early treatment and not always the last option in the treatment algorithm.
This PDF is available to Subscribers Only